13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001773206
Total reported value
$2.5B
$2.5B
81 檔
13.3%
At the close of Q4 2024, Integral Health Asset Management, LLC disclosed equity holdings valued at approximately $2.5B, spread across 81 reported holdings.
In Q4 2024, Integral Health Asset Management, LLC displayed an active expansion posture, initiating 33 new positions and adding to 29 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | Stock-Healthcare | 12.06% | -4.99% | +41.38% | |
| 2 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.30% | +1.22% | NEW | |
| 3 | BSX | Boston Scientific CORP | Stock-Healthcare | 4.19% | -0.13% | — | |
| 4 | VERA | Vera Therapeutics Inc | Stock-Other | 4.15% | -0.11% | +130.00% | |
| 5 | CYTK | Cytokinetics Inc | Stock-Healthcare | 4.01% | -2.82% | +33.33% | |
| 6 | CNC | Centene CORP | Stock-Healthcare | 2.58% | -0.26% | — | |
| 7 | CAH | Cardinal Health Inc | Stock-Healthcare | 2.52% | +0.09% | — | |
| 8 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.50% | +0.05% | +280.00% | |
| 9 | EHC | Encompass Health CORP | Stock-Healthcare | 2.36% | — | +9.09% | |
| 10 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 2.05% | +0.53% | +57.14% | |
| 11 | 2655787D | Blueprint Medicines CORP | Stock-Other | 2.04% | — | -5.17% | |
| 12 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.93% | +0.80% | +70.00% | |
| 13 | CVS | Cvs Health CORP | Stock-Healthcare | 1.91% | +3.97% | — | |
| 14 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.86% | +0.05% | — | |
| 15 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.78% | -0.77% | EXIT | |
| 16 | MCK | Mckesson CORP | Stock-Healthcare | 1.70% | — | — | |
| 17 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.70% | -0.66% | — | |
| 18 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 1.69% | — | +100.00% | |
| 19 | DGX | Quest Diagnostics Inc | Stock-Healthcare | 1.67% | +1.11% | +8.33% | |
| 20 | QURE | uniQure N.V. | Stock-Other | 1.66% | +0.94% | +175.00% | |
| 21 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 1.65% | -0.67% | EXIT | |
| 22 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.58% | +0.18% | NEW | |
| 23 | GILD | Gilead Sciences Inc | Stock-Healthcare | 1.57% | -0.67% | EXIT | |
| 24 | NARIUSD | Inari Medical Inc | Stock-Other | 1.52% | — | -12.50% | |
| 25 | SRRK | Scholar Rock Holding CORP | Stock-Other | 1.38% | +0.45% | +36.36% | |
| 26 | BTSG | Brightspring Health Services | Stock-Other | 1.38% | -1.03% | +90.00% | |
| 27 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 1.31% | — | — | |
| 28 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.26% | — | — | |
| 29 | JSPR | Jasper Therapeutics Inc | Stock-Other | 1.18% | — | +85.71% | |
| 30 | FMS | Fresenius Medical Care-adr | Stock-Other | 1.16% | -0.84% | EXIT | |
| 31 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 1.14% | — | — | |
| 32 | MDT | Medtronic plc | Stock-Healthcare | 1.02% | +0.62% | NEW | |
| 33 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 1.01% | +0.25% | — | |
| 34 | DXCM | Dexcom Inc | Stock-Healthcare | 0.99% | -0.53% | EXIT | |
| 35 | BNTX | Biontech Se-adr | Stock-Other | 0.97% | +0.18% | NEW | |
| 36 | WAT | Waters CORP | Stock-Healthcare | 0.95% | +0.59% | NEW | |
| 37 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.94% | — | — | |
| 38 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 0.92% | — | -9.09% | |
| 39 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 0.92% | -1.14% | +145.79% | |
| 40 | JANX | Janux Therapeutics Inc | Stock-Other | 0.91% | — | — | |
| 41 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 0.90% | — | +80.00% | |
| 42 | HUM | Humana Inc | Stock-Healthcare | 0.86% | — | — | |
| 43 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.80% | — | — | |
| 44 | COO | Cooper Cos Inc/the | Stock-Healthcare | 0.78% | -0.51% | EXIT | |
| 45 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.73% | — | — | |
| 46 | EXK | Exact Sciences CORP | Stock-Materials | 0.72% | — | +87.50% | |
| 47 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 0.72% | -0.09% | — | |
| 48 | ETNBGBP | 89bio Inc | Stock-Other | 0.67% | — | +100.00% | |
| 49 | ACLXGBX | Arcellx Inc | Stock-Other | 0.65% | — | -63.64% | |
| 50 | TARA | Protara Therapeutic Inc | Stock-Other | 0.63% | -0.21% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CNC | Centene CORP | +2.6% | NEW | New buy |
| 2 | CAH | Cardinal Health Inc | +2.5% | NEW | New buy |
| 3 | CVS | Cvs Health CORP | +1.9% | NEW | New buy |
| 4 | NBIX | Neurocrine Biosciences Inc | +1.9% | NEW | New buy |
| 5 | ISRG | Intuitive Surgical Inc | +1.8% | NEW | New buy |
| 6 | MCK | Mckesson CORP | +1.7% | NEW | New buy |
| 7 | VERA | Vera Therapeutics Inc | +1.7% | +130.00% | Add |
| 8 | GILD | Gilead Sciences Inc | +1.6% | NEW | New buy |
| 9 | LLY | Eli Lilly & Co | +1.5% | +280.00% | Add |
| 10 | QURE | uniQure N.V. | +1.4% | +175.00% | Add |
| 11 | AZNN | Astrazeneca Plc-spons Adr | +1.3% | NEW | New buy |
| 12 | APLSUSD | Apellis Pharmaceuticals Inc | +1.1% | NEW | New buy |
| 13 | SRRK | Scholar Rock Holding CORP | +1.1% | +36.36% | Add |
| 14 | ACHC | Acadia Healthcare Co Inc | +1% | NEW | New buy |
| 15 | WAT | Waters CORP | +1% | NEW | New buy |
| 16 | TEVA | Teva Pharmaceutical-sp Adr | +0.9% | NEW | New buy |
| 17 | JANX | Janux Therapeutics Inc | +0.9% | NEW | New buy |
| 18 | HUM | Humana Inc | +0.9% | NEW | New buy |
| 19 | OSCR | Oscar Health Inc - Class A | +0.8% | NEW | New buy |
| 20 | KRYS | Krystal Biotech Inc | +0.7% | NEW | New buy |
| 21 | RYTM | Rhythm Pharmaceuticals Inc | +0.7% | NEW | New buy |
| 22 | BMY | Bristol-myers Squibb Co | +0.7% | +100.00% | Add |
| 23 | TARA | Protara Therapeutic Inc | +0.6% | NEW | New buy |
| 24 | BTSG | Brightspring Health Services | +0.6% | +90.00% | Add |
| 25 | RGEN | Repligen CORP | +0.5% | NEW | New buy |
| 26 | ALHC | Alignment Healthcare Inc | +0.5% | NEW | New buy |
| 27 | ILMN | Illumina Inc | +0.5% | NEW | New buy |
| 28 | JSPR | Jasper Therapeutics Inc | +0.4% | +85.71% | Add |
| 29 | PODD | Insulet CORP | +0.4% | NEW | New buy |
| 30 | ARWR | Arrowhead Pharmaceuticals In | +0.4% | NEW | New buy |
| 31 | EWTX | Edgewise Therapeutics Inc | +0.4% | +70.00% | Add |
| 32 | MLYS | Mineralys Therapeutics Inc | +0.4% | +145.79% | Add |
| 33 | WBA | Walgreens Boots Alliance Inc | +0.4% | NEW | New buy |
| 34 | TGTX | Tg Therapeutics Inc | +0.4% | NEW | New buy |
| 35 | SWTXUSD | Springworks Therapeutics Inc | +0.3% | NEW | New buy |
| 36 | BNTX | Biontech Se-adr | +0.3% | +100.00% | Add |
| 37 | DYN | Dyne Therapeutics Inc | +0.3% | NEW | New buy |
| 38 | ZNTL | Zentalis Pharmaceuticals Inc | +0.3% | NEW | New buy |
| 39 | RVMD | Revolution Medicines Inc | +0.3% | +57.14% | Add |
| 40 | TARS | Tarsus Pharmaceuticals Inc | +0.3% | -6.67% | Trim |
| 41 | ETNBGBP | 89bio Inc | +0.3% | +100.00% | Add |
| 42 | INSM | Insmed Inc | +0.2% | +41.38% | Add |
| 43 | TVTX | Travere Therapeutics Inc | +0.2% | NEW | New buy |
| 44 | ALNY | Alnylam Pharmaceuticals Inc | +0.1% | +80.00% | Add |
| 45 | SLN | Silence Therapeutics Plc-adr | +0.1% | NEW | New buy |
| 46 | ATYR | Atyr Pharma Inc | +0.1% | NEW | New buy |
| 47 | EXK | Exact Sciences CORP | +0.1% | +87.50% | Add |
| 48 | ANRO | Alto Neuroscience Inc | +0.1% | NEW | New buy |
| 49 | FMS | Fresenius Medical Care-adr | +0.1% | +33.33% | Add |
| 50 | DXCM | Dexcom Inc | +0.1% | +25.00% | Add |
According to official SEC Form 13F filings, Integral Health Asset Management, LLC reported a total U.S. public equity portfolio value of $2.5B across 81 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including INSM, THC, BSX) accounted for 13.3% of total reported equity market value during Q4 2024.
Top New Position Initiated
CNC
市值: $30.3M
Top Position Liquidated / Trimmed
LONGBOARD PHARMACEUTICALS IN
前期市值: $35.0M
During Q4 2024, Integral Health Asset Management, LLC's top holdings by market value included INSM (12.1%)、THC (4.3%)、BSX (4.2%). The largest single position, INSM, represented 12.1% of total portfolio value.
In Q4 2024, Integral Health Asset Management, LLC made 94 total portfolio adjustments, initiating 33 new buys, adding to 29 positions, trimming 14 holdings, and fully liquidating 18 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.